• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

StemCells Inc.

StemCells to wind down operations after ending mid-stage study

June 2, 2016 By MassDevice

(Reuters) – StemCells Inc said it would wind down operations after the company terminated a mid-stage trial testing its therapy in spinal cord injury, sending its shares plummeting 85%. The magnitude of the treatment’s effect did not justify continuing the study given the financial resources available, StemCells said on Tuesday. The Newark, California-based biotech said […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: StemCells Inc.

StemCells says spinal injury therapy shows promise

November 20, 2015 By MassDevice

(Reuters) — StemCells Inc said its experimental stem cell therapy improved the functioning and strength of limbs in patients with spinal cord injuries, becoming the second company to report promising data on the treatment for such injuries. The biotech company said interim results from the mid-stage study showed 4 of 6 patients experienced an improvement on 2 different scales. […]

Filed Under: Clinical Trials, Regenerative Medicine Tagged With: StemCells Inc.

Pluristem launches Phase I clinical trial to treat tendonitis with stem cells

May 17, 2013 By Sony Salzman Leave a Comment

Pluristem Invasive Devices Inc. logo

Pluristem (NSDQ:PSTI) announced a new Phase I clinical trial to treat chronic tendonitis with the company’s PLX-PAD stem cell therapy.

Cell therapy has traditionally been used in cancer and cardiac treatments, but Pluristem is now applying the technology to sports-related injuries, where it has seen an increased interest among athletes and orthopedic surgeons.

Filed Under: News Well, Orthopedics, Stem Cells Tagged With: Aastron Biosciences, Clinical Trials, Geron Corp., InVivo Therapeutics, Pluristem, StemCells Inc.

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS